Introduction Metabolomics is an emerging approach for early detection of cancer. Along with
the development of metabolomics, high-throughput technologies and statistical learning, the …

Cancer is one of the major causes of mortality worldwide and its already large burden is
projected to increase significantly in the near future with a predicted 22 million new cancer …

The availability of robust classification algorithms for the identification of high risk individuals
with resectable disease is critical to improving early detection strategies and ultimately …

To examine the association between metabolic deregulation and pancreatic cancer, we
conducted a two-stage case–control targeted metabolomics study using prediagnostic sera …

Untargeted Nuclear Magnetic Resonance (NMR) metabolomics of polar extracts from the
pancreata of a caerulin-induced mouse model of pancreatitis (Pt) and of a transgenic mouse …

Diabetes mellitus (DM) is a complex disease with high prevalence of comorbidity and
mortality. DM is predicted to reach more than 700 million people by 2045. In recent years …

Abstract Background Carbohydrate antigen (CA) 19–9 is a known pancreatic cancer (PC)
biomarker, but is not commonly used for general screening due to its low sensitivity and …

Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with only 10% of patients
being eligible for surgical resection and with an R0 resection being attained in under 20 …